Bristol Myers Squibb (BMS) is an American pharmaceutical company, headquartered in New York City.

Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

BMS’s primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), New Brunswick, New Jersey, and Redwood City, California; with other sites in Devens and Cambridge, Massachusetts, East Syracuse, New York, Braine-l’Alleud, Belgium, Tokyo, Japan, Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).

Traded as:           NYSE: BMY; S&P 100 component; S&P 500 component

Industry:              Pharmaceuticals

Founded:            1887; 133 years ago

Founders:           William McLaren Bristol; John Ripley Myers; E. R. Squibb

Headquarters:   430 East 29th Street New York City, New York, United States

Website:              https://www.bms.com/

Bristol Myers Squibb to buy RayzeBio for $4.1 billion in cash

Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion

Bristol Myers Squibb announces 5.3% dividend increase

Bristol Myers Squibb Announces CEO Transition and New Board Chair

Bristol Myers Squibb completes acquisition of Forbius

Bristol-Myers Squibb to acquire Mirati Therapeutics for up to $5.8 billion

Sensyne Health signs research collaboration agreement with Bristol Myers Squibb